Necrotizing Ulcerative Gingivitis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Necrotizing Ulcerative Gingivitis (NUG) Treatment Landscape

Novartis International AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sanofi S.A.
GlaxoSmithKline plc
Merck & Co., Inc.
Otsuka Pharmaceutical Co., Ltd.
Abbott Laboratories
Eli Lilly and Company
Hindustan Antibiotics Limited

Browse Key Market Insights with Data Illustration:

Necrotizing Ulcerative Gingivitis (NUG) Treatment Market | Growth Outlook 2036

In the News

Sanofi S.A. declared an agreement with Septodont to divest a portfolio of the four dental care brands which include Ultracain, Rodogyl, Birodogyl, and Dontisolon, and medical devices. The portfolio contains medicines that are useful for both during and after dental operations.
U.S. Food and Drug Administration recalled a GUM PerioSheild, an oral health rinse of SUNSTAR as it was found contaminated with Burkholderia cepacian microorganisms.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of necrotizing ulcerative gingivitis treatment is evaluated at USD 1.12 Billion.

The necrotizing ulcerative gingivitis treatment market size was valued at USD 1.01 Billion in 2023 and is expected to exceed USD 4.42 Billion by the end of 2036, expanding at over 12.1% CAGR during the forecast period i.e., between 2024-2036. Growing incidences of oral diseases, and poor diet and dental hygiene are the major factors driving the market growth.

North America is likely to be the largest with a share of about 32% by 2036, attributed to increasing prevalence of oral diseases in developed countries, including the US, driven by poor diet, and high cases of diabetes amongst the people.

Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited

Necrotizing Ulcerative Gingivitis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Necrotizing Ulcerative Gingivitis (NUG) Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the necrotizing ulcerative gingivitis treatment market?

What are the factors driving the necrotizing ulcerative gingivitis treatment landscape?

Which region held the largest necrotizing ulcerative gingivitis treatment industry share?

Who are the key players in the necrotizing ulcerative gingivitis treatment sector?